Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001239241-15-000001
Filing Date
2015-06-19
Accepted
2015-06-19 20:58:32
Documents
1
Period of Report
2015-06-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 23651
  Complete submission text file 0001239241-15-000001.txt   25048
Mailing Address C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA RM 5508 NEW YORK NY 21264957
Business Address
EVNIN ANTHONY B (Reporting) CIK: 0001239241 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 15943503

Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2066960703
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

EIN.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)